论文部分内容阅读
活性碳抗癌剂是将丝裂霉素等抗癌剂吸附在活性碳微粒上治疗癌症。日本京都府立医科大学第一外科高桥俊雄教授等,使用活性碳抗癌剂,治疗出现淋巴结转移、腹膜、胸膜种植性转移的胃癌、大肠癌和乳腺癌患者。据报告其特点如下:1.根据抗癌剂的浓度梯度有调节地释放:2.具有较高的淋巴趋向性,可作为廓清淋巴结的指标;3.停留在腹膜、胸膜内的时间长;4.流入全身血液中的药物较少;可大剂量局部用药。治疗胃癌时,活性碳抗癌剂的用药方法分为两种。一种是术前在内窥镜下将活性碳注入
An activated carbon anticancer agent is an anticancer agent such as mitomycin which is adsorbed on activated carbon fine particles to treat cancer. Professor Takahashi Junxi, the first surgeon at Kyoto Prefectural University of Medical Sciences in Japan, used activated carbon anticancer agents to treat patients with lymph node metastasis, peritoneal, pleural implant metastases, gastric cancer, colorectal cancer, and breast cancer. According to the report, its characteristics are as follows: 1. According to the concentration gradient of anti-cancer agents to regulate the release: 2. With high lymphatic tropism, can be used as an indicator to clear lymph nodes; 3. Stay in the peritoneum, pleural long time; 4 Fewer drugs flow into the body’s blood; large doses can be used topically. In the treatment of gastric cancer, there are two methods for the use of active carbon anticancer agents. One is to inject activated carbon under an endoscope preoperatively